DOCSLIB.ORG

5-HT2C Receptor Blockade Reverses SSRI-Associated Basal Ganglia Dysfunction and Potentiates Therapeutic Efficacy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
5-HT2C Receptor Blockade Reverses SSRI-Associated Basal Ganglia Dysfunction and Potentiates Therapeutic Efficacy Molecular Psychiatry https://doi.org/10.1038/s41380-018-0227-x ARTICLE 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy 1,2 1 1 1 1,3 Elena Y. Demireva ● Deepika Suri ● Emanuela Morelli ● Darshini Mahadevia ● Nao Chuhma ● 1,2 1,2 1 1 1 1 Catia M. Teixeira ● Annette Ziolkowski ● Marc Hersh ● James Fifer ● Sneha Bagchi ● Alexei Chemiakine ● 1,4 1,2 1,2 1,3 1,2 Holly Moore ● Jay A. Gingrich ● Peter Balsam ● Stephen Rayport ● Mark S. Ansorge Received: 30 November 2016 / Revised: 13 July 2018 / Accepted: 24 July 2018 © Springer Nature Limited 2018 Abstract Serotonin (5-HT) selective reuptake inhibitors (SSRIs) are widely used in the treatment of depression and anxiety disorders, but responsiveness is uncertain and side effects often lead to discontinuation. Side effect profiles suggest that SSRIs reduce dopaminergic (DAergic) activity, but specific mechanistic insight is missing. Here we show in mice that SSRIs impair motor function by acting on 5-HT2C receptors in the substantia nigra pars reticulata (SNr), which in turn inhibits nigra pars compacta (SNc) DAergic neurons. SSRI-induced motor deficits can be reversed by systemic or SNr-localized 5-HT2C 1234567890();,: 1234567890();,: receptor antagonism. SSRIs induce SNr hyperactivity and SNc hypoactivity that can also be reversed by systemic 5-HT2C receptor antagonism. Optogenetic inhibition of SNc DAergic neurons mimics the motor deficits due to chronic SSRI treatment, whereas local SNr 5-HT2C receptor antagonism or optogenetic activation of SNc DAergic neurons reverse SSRI- induced motor deficits. Lastly, we find that 5-HT2C receptor antagonism potentiates the antidepressant and anxiolytic effects of SSRIs. Together our findings demonstrate opposing roles for 5-HT2C receptors in the effects of SSRIs on motor function and affective behavior, highlighting the potential benefits of 5-HT2C receptor antagonists for both reduction of motor side effects of SSRIs and augmentation of therapeutic antidepressant and anxiolytic effects. Introduction dysregulation influences psychiatric states, and most neu- ropsychiatric medications act in these two systems. How the 5-HT and DA neurotransmission are highly interconnected transmitter systems influence each other is of key importance in both normal brain function and disease. Their for understanding normal brain function, psychopathology, and pharmacotherapy. SSRIs that block the 5-HT transporter (5-HTT) are currently the most widely prescribed psychiatric drugs. They are prescribed not only as a first-line treatment These authors contributed equally: Elena Y. Demireva and Deepika Suri. for depressive disorders, but also for many other psychiatric disorders, including bipolar, obsessive-compulsive, panic Electronic supplementary material The online version of this article and generalized anxiety disorder. Despite their widespread (https://doi.org/10.1038/s41380-018-0227-x) contains supplementary fi material, which is available to authorized users. use, SSRIs face both ef cacy and side-effect challenges [1]. One hypothesis is that their therapeutic shortcomings arise * Mark S. Ansorge from 5-HTergic modulation of the DA system [2]. Indeed, [email protected] several side effects of SSRIs such as anhedonia, apathy, 1 Department of Psychiatry, Columbia University, New York, NY emotional blunting, reduced libido, akathisia, and extra- 10032, USA pyramidal motor symptoms (EPS) point to DAergic hypo- 2 Department of Developmental Neuroscience, New York State function in the behavioral and emotional effects of SSRIs Psychiatric Institute, New York, NY 10032, USA [3–8]. Animal studies support this idea, with several studies 3 Division of Molecular Therapeutics, New York State Psychiatric demonstrating inhibitory effects of pharmacologically Institute, New York, NY 10032, USA increased extracellular 5-HT on midbrain DAergic function 4 Division of Systems Neuroscience, New York State Psychiatric [9, 10]. In mice, and occasionally in predisposed patients, Institute, New York, NY 10032, USA E. Y. Demireva et al. such blunted DAergic function can induce parkinsonism weighed 25–35 g. All subjects were genotyped by PCR of [2, 11]. genomic DNA isolated from tissue samples harvested at To improve 5-HTT-based pharmacotherapy, one 18–21 days of age. approach has been to compensate for DAergic dysregula- tion by directly targeting the DA system with compounds Animal husbandry such as bupropion or amphetamines [12]. But such aug- mentation strategies, which broadly impact DA signaling, Animals were housed in groups of five per cage and pro- have had little success and can themselves have adverse vided with food and water ad libitum (except as noted). effects. A more targeted approach requires therapies that Animals were maintained on a 12 h light/dark cycle (8:00 A. directly address the mechanism by which SSRI-induced M./8:00 P.M.) Animal testing was conducted during the increase in 5-HTergic tone leads to DA hypofunction. To light phase of the light cycle. Animal testing was conducted that end, it is important to identify the 5-HT receptors in accordance with National Institutes of Health (NIH) whose activation is responsible for mediating the inhibitory Laboratory Animal Care and Welfare guidelines and effects on DA signaling. Among the fourteen 5-HT recep- approved by the Institutional Animal Care and Use Com- tors, one promising candidate is the 5-HT2C receptor, mittees of Columbia University and NYS Psychiatric which is expressed by SNr and VTA GABAergic neurons, Institute. and its antagonism reverses acute effects of SSRIs on VTA DAergic activity [13–15]. Furthermore, 5-HT2C receptor Animal use agonism reduces incentive motivation [16, 17], while antagonism increases motivation [18–20], with a hypothe- The numbers of mice used were based on a power analysis sized mechanism centered on 5-HT acting at 5-HT2C assuming a 30% mean effect size of manipulations and an receptors to reduce motivation by suppressing mesolimbic acceptable probability level of 0.05. Mice were randomized DAergic activity [20]. when allocated to treatment groups balancing for litter, sex, Here we investigate the role of 5-HT2C receptors in and genotype. Investigators were blinded to group alloca- mediating the effects of 5-HTT blockade on basal ganglia tions during testing and scoring. (BG) function and emotional behaviors. We find that 5- HT2C receptor activation plays a selective and pivotal role Drugs in the suppression of the DAergic nigrostriatal pathway associated with impaired motor function during SSRI Fluoxetine (FLX; ANAWA Trading SA, Wangen, Swit- treatment. We directly assess the roles of SNr 5-HT2C zerland), was dissolved in 0.9% NaCl or drinking water to receptors and SNc DAergic activity in regulating motor achieve 2.5, 5, or 10 mg/kg when administered intraper- function, and we investigate the interaction between 5-HTT itoneally (i.p.) or through the drinking water (see supple- blockade and 5-HT2C receptor antagonism in anxiety- and mentary data). The 5-HT2C receptor inverse agonist depression-related behavior. Our findings provide mechan- SB206553 (Tocris, Ellisville, MO), the 5-HT2C receptor istic insight into 5-HTergic modulation of DAergic function antagonist SB242084 (Tocris), the 5-HT2C receptor agonist and highlight 5-HT2C receptor antagonism for augmenta- WAY161503 (Tocris), and the 5-HT3 receptor antagonist tion therapy to improve antidepressant efficacy of SSRI ondansetron (Tocris) were dissolved by sonication in 0.9% treatment and reduce basal ganglia mediated side-effects. NaCl to achieve concentrations between 0.1 and 5 mg/kg when administered i.p. For local infusions, SB242084 was first dissolved in DMSO to 10 mg/ml, and then diluted at Materials and methods 1:100 in saline to obtain a final concentration of 0.1 mg/ml. Transgenic mice In vivo electrophysiology Mice heterozygous for the 5-htt mutation (5-htt+/−,10th– Extracellular recording microelectrodes (2.0 mm OD bor- 12th generation 129S6/SvEv) were crossed to produce 5-htt osilicate glass capillary tubing, ~1 µm tip diameter, impe- +/+, 5-htt+/-, and 5-htt-/- offspring see [21]. Independent dance 5–10 MOhms) were filled with 2 M NaCl containing groups of male subjects weighing 25–45 g were experi- 2% pontamine sky blue dye. The electrode signal was mentally tested at ages 2–13 months. Heterozygous cross- amplified, filtered and discriminated from noise. Mice were ings were also used to generate experimental groups of +/+ anesthetized with isoflurane 1–2% in oxygen via a standard and −/− mice for htr1a [22], htr1b [23], htr2a [24], and veterinary inhalation anesthesia apparatus. Body tempera- htr4 [25]. Offspring resulting from these crosses were ture was monitored by a rectal probe and maintained experimentally tested at approximately 5 months of age and between 36–37 °C using a water circulation pad placed 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic. under a clean gauze pad. A hole was drilled through the virus was allowed to express for 3 weeks, after which the skull overlying the brain structures of interest, and the dura animals were euthanized, and 300 µm horizontal brains was then punctured. A glass electrode was lowered with a slices containing ventral midbrain were sliced using vibra- hydraulic microdrive into the SNc and SNr at coordinates: tome (VT1200S, Leica). Electrophysiological recordings anterior/posterior (AP) +4.0 mm, medial/lateral (ML) 1.1– were performed in regular ACSF (in mM: 125 NaCl, 2.5 2.3 mm from Bregma, and dorsal/ventral (DV) 3.5–5.5 mm KCl, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2 and from brain surface. DAergic and non-DAergic neurons were 25 glucose, pH 7.4) saturated with 95% O2,5%CO2 at identified using established electrophysiological criteria [26, 31–33 °C. Patch pipettes contained the following solution 27] and once isolated, spontaneous activity was recorded for (in mM): 135 Cs+-methane sulfonate (MeSO4), 5 KCl, 2–3 min. The SNc and SNr were systematically investigated 2 MgCl2, 0.1 CaCl2, 10 HEPES, 1 EGTA, 2 ATP and 0.1 by recording from 4–6 tracks within a region per mouse.
Load more

Recommended publications
  • G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
    Int. J. Mol. Sci. 2014, 15, 1112-1142; doi:10.3390/ijms15011112 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes Benoît T. Roux 1 and Graeme S. Cottrell 2,* 1 Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK; E-Mail: [email protected] 2 Reading School of Pharmacy, University of Reading, Reading RG6 6UB, UK * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-118-378-7027; Fax: +44-118-378-4703. Received: 4 December 2013; in revised form: 20 December 2013 / Accepted: 8 January 2014 / Published: 16 January 2014 Abstract: G protein-coupled receptors (GPCRs) are important cell signaling mediators, involved in essential physiological processes. GPCRs respond to a wide variety of ligands from light to large macromolecules, including hormones and small peptides. Unfortunately, mutations and dysregulation of GPCRs that induce a loss of function or alter expression can lead to disorders that are sometimes lethal. Therefore, the expression, trafficking, signaling and desensitization of GPCRs must be tightly regulated by different cellular systems to prevent disease. Although there is substantial knowledge regarding the mechanisms that regulate the desensitization and down-regulation of GPCRs, less is known about the mechanisms that regulate the trafficking and cell-surface expression of newly synthesized GPCRs. More recently, there is accumulating evidence that suggests certain GPCRs are able to interact with specific proteins that can completely change their fate and function. These interactions add on another level of regulation and flexibility between different tissue/cell-types.
    [Show full text]
  • Melanopsin: an Opsin in Melanophores, Brain, and Eye
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 340–345, January 1998 Neurobiology Melanopsin: An opsin in melanophores, brain, and eye IGNACIO PROVENCIO*, GUISEN JIANG*, WILLEM J. DE GRIP†,WILLIAM PA¨R HAYES‡, AND MARK D. ROLLAG*§ *Department of Anatomy and Cell Biology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; †Institute of Cellular Signaling, University of Nijmegen, 6500 HB Nijmegen, The Netherlands; and ‡Department of Biology, The Catholic University of America, Washington, DC 20064 Edited by Jeremy Nathans, Johns Hopkins University School of Medicine, Baltimore, MD, and approved November 5, 1997 (received for review September 16, 1997) ABSTRACT We have identified an opsin, melanopsin, in supernatants subjected to SDSyPAGE analysis and subse- photosensitive dermal melanophores of Xenopus laevis. Its quent electroblotting onto a poly(vinylidene difluoride) mem- deduced amino acid sequence shares greatest homology with brane. The blot was probed with a 1:2,000 dilution of antisera cephalopod opsins. The predicted secondary structure of (CERN 886) raised against bovine rhodopsin and detected by melanopsin indicates the presence of a long cytoplasmic tail enhanced chemiluminescence. with multiple putative phosphorylation sites, suggesting that cDNA Library Screen. A X. laevis dermal melanophore this opsin’s function may be finely regulated. Melanopsin oligo(dT) cDNA library was screened with a mixture of mRNA is expressed in hypothalamic sites thought to contain 32P-labeled probes. Probes were synthesized by random prim- deep brain photoreceptors and in the iris, a structure known ing of TA-cloned (Invitrogen) fragments of X. laevis rhodopsin to be directly photosensitive in amphibians. Melanopsin mes- (7) (759 bp) and violet opsin (8) (279 bp) cDNAs.
    [Show full text]
  • The Vertebrate Ancestral Repertoire of Visual Opsins, Transducin Alpha Subunits and Oxytocin/Vasopressin Receptors Was Establish
    Lagman et al. BMC Evolutionary Biology 2013, 13:238 http://www.biomedcentral.com/1471-2148/13/238 RESEARCH ARTICLE Open Access The vertebrate ancestral repertoire of visual opsins, transducin alpha subunits and oxytocin/ vasopressin receptors was established by duplication of their shared genomic region in the two rounds of early vertebrate genome duplications David Lagman1†, Daniel Ocampo Daza1†, Jenny Widmark1,XesúsMAbalo1, Görel Sundström1,2 and Dan Larhammar1* Abstract Background: Vertebrate color vision is dependent on four major color opsin subtypes: RH2 (green opsin), SWS1 (ultraviolet opsin), SWS2 (blue opsin), and LWS (red opsin). Together with the dim-light receptor rhodopsin (RH1), these form the family of vertebrate visual opsins. Vertebrate genomes contain many multi-membered gene families that can largely be explained by the two rounds of whole genome duplication (WGD) in the vertebrate ancestor (2R) followed by a third round in the teleost ancestor (3R). Related chromosome regions resulting from WGD or block duplications are said to form a paralogon. We describe here a paralogon containing the genes for visual opsins, the G-protein alpha subunit families for transducin (GNAT) and adenylyl cyclase inhibition (GNAI), the oxytocin and vasopressin receptors (OT/VP-R), and the L-type voltage-gated calcium channels (CACNA1-L). Results: Sequence-based phylogenies and analyses of conserved synteny show that the above-mentioned gene families, and many neighboring gene families, expanded in the early vertebrate WGDs. This allows us to deduce the following evolutionary scenario: The vertebrate ancestor had a chromosome containing the genes for two visual opsins, one GNAT, one GNAI, two OT/VP-Rs and one CACNA1-L gene.
    [Show full text]
  • The Photopigment Melanopsin Is Exclusively Present in Pituitary
    The Journal of Neuroscience, 2002, Vol. 22 RC191 1of7 The Photopigment Melanopsin Is Exclusively Present in Pituitary Adenylate Cyclase-Activating Polypeptide-Containing Retinal Ganglion Cells of the Retinohypothalamic Tract Jens Hannibal, Peter Hindersson, Sanne M. Knudsen, Birgitte Georg, and Jan Fahrenkrug Department of Clinical Biochemistry, Bispebjerg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark Mammalian circadian rhythms generated in the hypothalamic strate that the distribution of melanopsin was identical to that of suprachiasmatic nuclei are entrained to the environmental light/ the PACAP-containing retinal ganglion cells. Colocalization dark cycle via a monosynaptic pathway, the retinohypothalamic studies using the specific melanopsin antibody and/or cRNA tract (RHT). We have shown previously that retinal ganglion probes in combination with PACAP immunostaining revealed cells containing pituitary adenylate cyclase-activating polypep- that melanopsin was found exclusively in the PACAP- tide (PACAP) constitute the RHT. Light activates the RHT via containing retinal ganglion cells located at the surface of so- unknown photoreceptors different from the classical photore- mata and dendrites. These data, in conjunction with published ceptors located in the outer retina. Two types of photopig- action spectra analyses and work in retinally degenerated (rd/ ments, melanopsin and the cryptochromes (CRY1 and CRY2), rd/cl) mutant mice, suggest that melanopsin is a circadian both of which are located in the inner retina, have been sug- photopigment located in retinal ganglion cells projecting to the gested as “circadian photopigments.” In the present study, we biological clock. cloned rat melanopsin photopigment cDNA and produced a specific melanopsin antibody. Using in situ hybridization histo- Key words: colocalization; suprachiasmatic nucleus; circa- chemistry combined with immunohistochemistry, we demon- dian rhythm; rat; immunohistochemistry; melanopsin antibodies Mammalian circadian rhythms of behavior and physiology are are unknown.
    [Show full text]
  • Color Vision Deficiency
    Color vision deficiency Description Color vision deficiency (sometimes called color blindness) represents a group of conditions that affect the perception of color. Red-green color vision defects are the most common form of color vision deficiency. Affected individuals have trouble distinguishing between some shades of red, yellow, and green. Blue-yellow color vision defects (also called tritan defects), which are rarer, cause problems with differentiating shades of blue and green and cause difficulty distinguishing dark blue from black. These two forms of color vision deficiency disrupt color perception but do not affect the sharpness of vision (visual acuity). A less common and more severe form of color vision deficiency called blue cone monochromacy causes very poor visual acuity and severely reduced color vision. Affected individuals have additional vision problems, which can include increased sensitivity to light (photophobia), involuntary back-and-forth eye movements (nystagmus) , and nearsightedness (myopia). Blue cone monochromacy is sometimes considered to be a form of achromatopsia, a disorder characterized by a partial or total lack of color vision with other vision problems. Frequency Red-green color vision defects are the most common form of color vision deficiency. This condition affects males much more often than females. Among populations with Northern European ancestry, it occurs in about 1 in 12 males and 1 in 200 females. Red- green color vision defects have a lower incidence in almost all other populations studied. Blue-yellow color vision defects affect males and females equally. This condition occurs in fewer than 1 in 10,000 people worldwide. Blue cone monochromacy is rarer than the other forms of color vision deficiency, affecting about 1 in 100,000 people worldwide.
    [Show full text]
  • G Protein-Coupled Receptors in the Hypothalamic Paraventricular and Supraoptic Nuclei – Serpentine Gateways to Neuroendocrine Homeostasis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Frontiers in Neuroendocrinology 33 (2012) 45–66 Contents lists available at ScienceDirect Frontiers in Neuroendocrinology journal homepage: www.elsevier.com/locate/yfrne Review G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei – serpentine gateways to neuroendocrine homeostasis Georgina G.J. Hazell, Charles C. Hindmarch, George R. Pope, James A. Roper, Stafford L. Lightman, ⇑ David Murphy, Anne-Marie O’Carroll, Stephen J. Lolait Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dorothy Hodgkin Building, School of Clinical Sciences, University of Bristol, Whitson Street, Bristol BS1 3NY, UK article info abstract Article history: G protein-coupled receptors (GPCRs) are the largest family of transmembrane receptors in the mamma- Available online 23 July 2011 lian genome. They are activated by a multitude of different ligands that elicit rapid intracellular responses to regulate cell function. Unsurprisingly, a large proportion of therapeutic agents target these receptors. Keywords: The paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus are important G protein-coupled receptor mediators in homeostatic control. Many modulators of PVN/SON activity, including neurotransmitters Paraventricular nucleus and hormones act via GPCRs – in fact over 100 non-chemosensory GPCRs have been detected in either Supraoptic nucleus the PVN or SON. This review provides a comprehensive summary of the expression of GPCRs within Vasopressin the PVN/SON, including data from recent transcriptomic studies that potentially expand the repertoire Oxytocin Corticotropin-releasing factor of GPCRs that may have functional roles in these hypothalamic nuclei.
    [Show full text]
  • Development of the Pattern of Photoreceptors in the Chick Retina
    The Journal of Neuroscience, February 15, 1996, 16(4):1430-1439 Development of the Pattern of Photoreceptors in the Chick Retina Suzanne L. Bruhn and Constance L. Cepko Department of Genetics, Harvard Medical School, Boston, Massachusetts 02175 The various classes of photoreceptor cells found in vertebrate differences in the localization of RNA within the inner segment retinae are organized in specific patterns, which are important of cone photoreceptors, suggesting that morphological differ- for visual function. It is not known how these patterns are entiation preceded the expression of photopigment molecules. achieved during development. The chick retina provides an Marked differences in the distribution of rods and cones were excellent model system in which to investigate this issue, con- also found. Within the area centralis, a circular rod-free zone taining cone opsins red, green, blue, and violet, as well as the bisected by a narrow rod-sparse region along the nasal-tem- rod-specific opsin rhodopsin. In this study, whole-mount in situ poral axis was evident as soon as rhodopsin RNA could be hybridization has revealed striking differences among opsins in detected. Such specialized regions appear to be set aside soon both spatial and temporal aspects of expression. The long- after photoreceptor cells become postmitotic, as evidenced by wavelength cone opsins, red and green, were first detected in a spatially restricted pattern of visinin RNA observed at E7. The a small spot within the area centralis at embryonic day 14 (El 4). onset of particular opsins in restricted regions of the retina In contrast, the short-wavelength cone opsins, blue and violet, suggest an underlying pattern related to visual function in the were not detected until 2 d later and showed domains of chick.
    [Show full text]
  • Structure and Function in Rhodopsin: the Fate of Opsin Formed Upon The
    Proc. Natl. Acad. Sci. USA Vol. 92, pp. 249-253, January 1995 Biochemistry Structure and function in rhodopsin: The fate of opsin formed upon the decay of light-activated metarhodopsin II in vitro (opsin unfolding/folding/denaturation/11-is-retinal/chromophore/regeneration) TAKESHI SAKAMOTO* AND H. GOBIND KHORANA Departments of Biology and Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139 Contributed by H. Gobind Khorana, September 8, 1994 ABSTRACT We report that the light-activated bovine parallels the rate of decay of the Meta II intermediate. Thus, the metarhodopsin II, upon decay, first forms opsin in the cor- opsin formed upon decay of this intermediate regains the con- rectly folded form. The latter binds ll1-is-retinal and regen- formation ofthe native ground-state opsin. However, while being erates the native rhodopsin chromophore. However, when the kept in the dark in DM, the opsin converts to one or more opsin formed upon metarhodopsin II decay is kept in 0.1% non-11-cis-retinal-binding forms in a time-dependent manner. dodecyl maltoside, it converts in a time-dependent manner to Upon subsequent addition of 11-cis-retinal, a slow regeneration a form(s) that does not bind ll-cis-retinal. On subsequent of the native rhodopsin chromophore is observed. Usually, three addition of ll-cis-retinal, slow reversal of the non-retinal- rate components are observed for this process: the first, a rapid binding forms to the correctly folded retinal-binding form has one (t1l2 = 15-60 sec) ascribed to the surviving correctly folded been demonstrated.
    [Show full text]
  • Theoretical Study of the Interaction of Agonists with the 5-HT2A Receptor
    Theoretical study of the interaction of agonists with the 5-HT2A receptor Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat) der Fakultät für Chemie und Pharmazie der Universität Regensburg vorgelegt von Maria Elena Silva aus Buccinasco Regensburg 2008 Die vorliegende Arbeit wurde in der Zeit von Oktober 2004 bis August 2008 an der Fakultät für Chemie und Pharmazie der Universität Regensburg in der Arbeitsgruppe von Prof. Dr. A. Buschauer unter der Leitung von Prof. Dr. S. Dove angefertigt Die Arbeit wurde angeleitet von: Prof. Dr. S. Dove Promotiongesucht eingereicht am: 28. Juli 2008 Promotionkolloquium am 26. August 2008 Prüfungsausschuß: Vorsitzender: Prof. Dr. A. Buschauer 1. Gutachter: Prof. Dr. S. Dove 2. Gutachter: Prof. Dr. S. Elz 3. Prüfer: Prof. Dr. H.-A. Wagenknecht I Contents 1 Introduction ......................................................................................................... 1 1.1 G protein coupled receptors .....................................................................................1 1.1.1 GPCR classification ............................................................................................2 1.1.2 Signal transduction mechanisms in GPCRs .......................................................4 1.2 Serotonin (5-hydroxytryptamine, 5-HT) ....................................................................7 1.2.1 Historical overview ..............................................................................................7 1.2.2 Biosynthesis and metabolism
    [Show full text]
  • The Vertebrate Ancestral Repertoire of Visual Opsins, Transducin Alpha Subunits and Oxytocin/ Vasopressin Receptors Was Establis
    Lagman et al. BMC Evolutionary Biology 2013, 13:238 http://www.biomedcentral.com/1471-2148/13/238 RESEARCH ARTICLE Open Access The vertebrate ancestral repertoire of visual opsins, transducin alpha subunits and oxytocin/ vasopressin receptors was established by duplication of their shared genomic region in the two rounds of early vertebrate genome duplications David Lagman1†, Daniel Ocampo Daza1†, Jenny Widmark1,XesúsMAbalo1, Görel Sundström1,2 and Dan Larhammar1* Abstract Background: Vertebrate color vision is dependent on four major color opsin subtypes: RH2 (green opsin), SWS1 (ultraviolet opsin), SWS2 (blue opsin), and LWS (red opsin). Together with the dim-light receptor rhodopsin (RH1), these form the family of vertebrate visual opsins. Vertebrate genomes contain many multi-membered gene families that can largely be explained by the two rounds of whole genome duplication (WGD) in the vertebrate ancestor (2R) followed by a third round in the teleost ancestor (3R). Related chromosome regions resulting from WGD or block duplications are said to form a paralogon. We describe here a paralogon containing the genes for visual opsins, the G-protein alpha subunit families for transducin (GNAT) and adenylyl cyclase inhibition (GNAI), the oxytocin and vasopressin receptors (OT/VP-R), and the L-type voltage-gated calcium channels (CACNA1-L). Results: Sequence-based phylogenies and analyses of conserved synteny show that the above-mentioned gene families, and many neighboring gene families, expanded in the early vertebrate WGDs. This allows us to deduce the following evolutionary scenario: The vertebrate ancestor had a chromosome containing the genes for two visual opsins, one GNAT, one GNAI, two OT/VP-Rs and one CACNA1-L gene.
    [Show full text]
  • Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties
    Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties Jufang Shan1, George Khelashvili1, Sayan Mondal1, Ernest L. Mehler1, Harel Weinstein1,2* 1 Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York, United States of America, 2 The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, New York, United States of America Abstract From computational simulations of a serotonin 2A receptor (5-HT2AR) model complexed with pharmacologically and structurally diverse ligands we identify different conformational states and dynamics adopted by the receptor bound to the full agonist 5-HT, the partial agonist LSD, and the inverse agonist Ketanserin. The results from the unbiased all-atom molecular dynamics (MD) simulations show that the three ligands affect differently the known GPCR activation elements including the toggle switch at W6.48, the changes in the ionic lock between E6.30 and R3.50 of the DRY motif in TM3, and the dynamics of the NPxxY motif in TM7. The computational results uncover a sequence of steps connecting these experimentally-identified elements of GPCR activation. The differences among the properties of the receptor molecule interacting with the ligands correlate with their distinct pharmacological properties. Combining these results with quantitative analysis of membrane deformation obtained with our new method (Mondal et al, Biophysical Journal 2011), we show that distinct conformational rearrangements produced by the three ligands also elicit different responses in the surrounding membrane. The differential reorganization of the receptor environment is reflected in (i)-the involvement of cholesterol in the activation of the 5-HT2AR, and (ii)-different extents and patterns of membrane deformations.
    [Show full text]
  • Evolution of Mammalian Opn5 As a Specialized UV-Absorbing Title Pigment by a Single Amino Acid Mutation
    Evolution of mammalian Opn5 as a specialized UV-absorbing Title pigment by a single amino acid mutation. Yamashita, Takahiro; Ono, Katsuhiko; Ohuchi, Hideyo; Yumoto, Akane; Gotoh, Hitoshi; Tomonari, Sayuri; Sakai, Author(s) Kazumi; Fujita, Hirofumi; Imamoto, Yasushi; Noji, Sumihare; Nakamura, Katsuki; Shichida, Yoshinori Citation The Journal of biological chemistry (2014), 289(7): 3991-4000 Issue Date 2014-02-14 URL http://hdl.handle.net/2433/203075 This research was originally published in [ The Journal of Biological Chemistry, 289, 3991-4000. doi: Right 10.1074/jbc.M113.514075 © the American Society for Biochemistry and Molecular Biology Type Journal Article Textversion author Kyoto University Molecular property and expression pattern of mammalian Opn5 Evolution of mammalian Opn5 as a specialized UV-absorbing pigment by a single amino acid mutation* Takahiro Yamashita1,6, Katsuhiko Ono2,6, Hideyo Ohuchi3,6, Akane Yumoto1, Hitoshi Gotoh2, Sayuri Tomonari4, Kazumi Sakai1, Hirofumi Fujita3, Yasushi Imamoto1, Sumihare Noji4, Katsuki Nakamura5, and Yoshinori Shichida1 1Department of Biophysics, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan, 2Department of Biology, Kyoto Prefectural University of Medicine, Kyoto 603-8334, Japan, 3Department of Cytology and Histology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan, 4Department of Life Systems, Institute of Technology and Science, University of Tokushima Graduate School, Tokushima 770-8506, Japan, 5Primate Research Institute, Kyoto University, Inuyama, Aichi 484-8506, Japan. *Running title: Molecular property and expression pattern of mammalian Opn5 Correspondence should be addressed to Y.S. ([email protected]) 6These authors contributed equally to this work. Keywords: Rhodopsin; Photoreceptors; Signal transduction; G proteins; Molecular evolution; non- visual photoreception Background: Opn5 is considered to regulate non-visual photoreception in the retina and brain of animals.
    [Show full text]